Paper37544835
Neuropsychiatric Symptoms and Alzheimer Disease Biomarkers Independently Predict Progression to Incident Cognitive Impairment.
Babulal GM and 5 others. Am J Geriatr Psychiatry, 2023. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Neuropsychiatric Symptoms and Alzheimer Disease Biomarkers Independently Predict Progression to Incident Cognitive Impairment. Papers, record 37544835. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37544835
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Cognitive Dysfunction | Major topic |
| Humans | |
| Aged | |
| Longitudinal Studies | |
| Prospective Studies | |
| Amyloid beta-Peptides | |
| tau Proteins | |
| Biomarkers | |
| Positron-Emission Tomography | |
| Peptide Fragments | |
| Disease Progression |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 AG066444 | NIA NIH HHS | United States | P30AG066444 | PubMed and NIH | NIH RePORTER |
| R01 AG068183 | NIA NIH HHS | United States | R01AG068183 | PubMed and NIH | NIH RePORTER |
| P01 AG003991 | NIA NIH HHS | United States | P01AG003991 | PubMed | NIH RePORTER |
| P01 AG026276 | NIA NIH HHS | United States | P01AG026276 | PubMed and NIH | NIH RePORTER |
| R01 AG067428 | NIA NIH HHS | United States | R01AG067428 | PubMed and NIH | NIH RePORTER |
| R01 AG056466 | NIA NIH HHS | United States | R01AG056466 | PubMed and NIH | NIH RePORTER |
References54
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30615028 | Assessment of Racial Disparities in Biomarkers for Alzheimer Disease. | JAMA Neurol | 2019 | https://conductscience.org/library/papers/30615028 | PubMed |
| 2 | 35103400 | Mild behavioral impairment is associated with progression to Alzheimer's disease: A clinicopathological study. | Alzheimers Dement | 2022 | https://conductscience.org/library/papers/35103400 | PubMed |
| 3 | 31914223 | Mild behavioral impairment is associated with β-amyloid but not tau or neurodegeneration in cognitively intact elderly individuals. | Alzheimers Dement | 2020 | https://conductscience.org/library/papers/31914223 | PubMed |
| 4 | 29501462 | Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging. | Alzheimers Dement | 2018 | https://conductscience.org/library/papers/29501462 | PubMed |
| 5 | 36840665 | Racial and ethnic differences in neuropsychiatric symptoms and progression to incident cognitive impairment among community-dwelling participants. | Alzheimers Dement | 2023 | https://conductscience.org/library/papers/36840665 | PubMed |
| 6 | 25585033 | Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study. | Am J Psychiatry | 2015 | https://conductscience.org/library/papers/25585033 | PubMed |
| 7 | 10811551 | Interrater reliability of the Clinical Dementia Rating in a multicenter trial. | J Am Geriatr Soc | 2000 | https://conductscience.org/library/papers/10811551 | PubMed |
| 8 | 31371569 | High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis. | Neurology | 2019 | https://conductscience.org/library/papers/31371569 | PubMed |
| 9 | 31771056 | Early Emergence of Neuropsychiatric Symptoms in Cognitively Normal Subjects and Mild Cognitive Impairment. | J Alzheimers Dis | 2020 | https://conductscience.org/library/papers/31771056 | PubMed |
| 10 | 33816761 | Association between regional tau pathology and neuropsychiatric symptoms in aging and dementia due to Alzheimer's disease. | Alzheimers Dement (N Y) | 2021 | https://conductscience.org/library/papers/33816761 | PubMed |
| 11 | 30304397 | Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers. | Brain | 2018 | https://conductscience.org/library/papers/30304397 | PubMed |
| 12 | 30847382 | Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies. | Alzheimers Dement (Amst) | 2019 | https://conductscience.org/library/papers/30847382 | PubMed |
| 13 | 34742925 | The global prevalence of major depressive disorder (MDD) among the elderly: A systematic review and meta-analysis. | Neurosci Biobehav Rev | 2022 | https://conductscience.org/library/papers/34742925 | PubMed |
| 14 | 16894109 | Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI. | Neurology | 2006 | https://conductscience.org/library/papers/16894109 | PubMed |
| 15 | 29802030 | Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease. | Alzheimers Dement | 2018 | https://conductscience.org/library/papers/29802030 | PubMed |
| 16 | 36526487 | Depression, Depression Treatments, and Risk of Incident Dementia: A Prospective Cohort Study of 354,313 Participants. | Biol Psychiatry | 2023 | https://conductscience.org/library/papers/36526487 | PubMed |
| 17 | 29325447 | Longitudinal Association of Amyloid Beta and Anxious-Depressive Symptoms in Cognitively Normal Older Adults. | Am J Psychiatry | 2018 | https://conductscience.org/library/papers/29325447 | PubMed |
| 18 | 16372280 | Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. | Ann Neurol | 2006 | https://conductscience.org/library/papers/16372280 | PubMed |
| 19 | 25114531 | Perspectives on perceived stigma and self-stigma in adult male patients with depression. | Neuropsychiatr Dis Treat | 2014 | https://conductscience.org/library/papers/25114531 | PubMed |
| 20 | 36323521 | Plasma Phosphorylated Tau at Threonine 181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease. | Neurology | 2023 | https://conductscience.org/library/papers/36323521 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41219110 | Neuropsychiatric symptoms in Alzheimer's disease: Bridging mechanisms, management, and emerging innovations. | Neurotherapeutics | 2026 | https://conductscience.org/library/papers/41219110 | PubMed |
| 40964168 | Anxious-depressive symptoms and sleep disturbances across the Alzheimer disease spectrum. | Nat Ment Health | 2025 | https://conductscience.org/library/papers/40964168 | PubMed |
| 40851415 | Late-life emergence of neuropsychiatric symptoms and risk of cognitive impairment in cognitively unimpaired individuals. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/40851415 | PubMed |
| 40361900 | Mapping the Neuropsychiatric Symptoms in Alzheimer's Disease Using Biomarkers, Cognitive Abilities, and Personality Traits: A Systematic Review. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40361900 | PubMed |
| 40356018 | Study partner characteristics moderate the prediction of cognitive decline in aging. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/40356018 | PubMed |
| 40108701 | Tau-PET pathology in the subregions of the amygdala and its associations with cognitive performance and neuropsychiatric symptoms in autosomal dominant Alzheimer's disease. | Alzheimers Res Ther | 2025 | https://conductscience.org/library/papers/40108701 | PubMed |
| 39551647 | Practical Assessment of Neuropsychiatric Symptoms: Updated Reliability, Validity, and Cutoffs for the Neuropsychiatric Inventory Questionnaire. | Am J Geriatr Psychiatry | 2025 | https://conductscience.org/library/papers/39551647 | PubMed |
| 38995786 | Cognition Mediates the Association Between Cerebrospinal Fluid Biomarkers of Amyloid and P-Tau and Neuropsychiatric Symptoms. | J Alzheimers Dis | 2024 | https://conductscience.org/library/papers/38995786 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37544835
GET https://conductscience.org/api/papers/v1/37544835/references?page=2